Skip to main content
Access Resources

MJFF Publications

4891 - 4900 of 7540 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson’s Disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2018.00967
    Citation Count: 13
  • RESTRICTED
    Title: Reduced gray matter volume in cognitively preserved COMT 158Val/Val Parkinson’s disease patients and its association with cognitive decline
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11682-018-0022-y
    Best OA location URL:
    Citation Count: 12
  • RESTRICTED
    Title: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/2168479018817517;
    Best OA location URL:
    Citation Count: 21
  • RESTRICTED
    Title: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms20010141
    Citation Count: 52
  • RESTRICTED
    Title: Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1172/jci120848
    Citation Count: 107
  • RESTRICTED
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Best OA location URL:
    Citation Count: 28
  • RESTRICTED
    Title: Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.004
    Best OA location URL:
    Citation Count: 15
  • RESTRICTED
    Title: Abstract
    Journal Name: Brain and Neuroscience Advances
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/2398212819855490
    Citation Count: 2
  • RESTRICTED
    Title: Alzheimer's Disease and Its Potential Alternative Therapeutics.
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.4172/2161-0460.1000477
    Best OA location URL:
    Citation Count: 11
  • RESTRICTED
    Title: Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.trci.2019.08.005
    Citation Count: 13
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.